What is the address of Dr. J-P Similon Médecine Générale?

The registered office of Dr. J-P Similon Médecine Générale is located at Rue de la Station,Moustier 189, 5190 Jemeppe-sur-Sambre.

Is Dr. J-P Similon Médecine Générale still active?

Yes. According to the CBE (31 October 2026) Dr. J-P Similon Médecine Générale is active, legal situation “Normale toestand”, started on 4 September 2019.

Is Dr. J-P Similon Médecine Générale registered on Peppol?

No, Dr. J-P Similon Médecine Générale is currently not registered on the Peppol network.

What is the enterprise number of Dr. J-P Similon Médecine Générale?

The enterprise number of Dr. J-P Similon Médecine Générale is BE0733707901.

When was Dr. J-P Similon Médecine Générale founded?

Dr. J-P Similon Médecine Générale was founded on 4 September 2019.

Who are the directors of Dr. J-P Similon Médecine Générale?

According to the 2025 annual accounts, the directors of Dr. J-P Similon Médecine Générale are: ANNE DEOM, JEAN-POL SIMILON.

Is Dr. J-P Similon Médecine Générale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 September 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. J-P Similon Médecine Générale make in 2025?

Dr. J-P Similon Médecine Générale posted a profit after taxes of € 16,135 in financial year 2025.

What is the revenue of Dr. J-P Similon Médecine Générale?

As a small company, Dr. J-P Similon Médecine Générale is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 34,382.

Dr. J-P Similon Médecine Générale (Private Limited)

Dossier Dr. J-P Similon Médecine Générale, printed on 31 October 2026 from databakkes.be/en/0733707901/dr-j-p-similon-medecine-generale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. J-P Similon Médecine Générale from Jemeppe-sur-Sambre, company number BE0733707901, closed financial year 2025 with a result of € 16,135 after tax. For that financial year Dr. J-P Similon Médecine Générale recorded a gross margin of € 34,382 and equity of € 53,494. Compared with financial year 2024, the result moved from € 19,591 to € 16,135. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 53,494

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 16,135

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 55,251

▲ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 7,000 paid out

43 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 24,089

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 26,558

▼ 14% vs 2024

€ 4,476 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 103

▼ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,736

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 57,286 Revenue 2024: € 57,286 First fiscal year in the series	-
Gross margin	€ 21,398 Gross margin 2022: € 21,398 First fiscal year in the series	€ 27,136 Gross margin 2023: € 27,136 ▲ 27% vs 2022 (€ 21,398) Favourable step	€ 40,084 Gross margin 2024: € 40,084 ▲ 48% vs 2023 (€ 27,136) Favourable step	€ 34,382 Gross margin 2025: € 34,382 ▼ 14% vs 2024 (€ 40,084) Unfavourable step	▼ 14%
Profit after taxes	€ 13,511 Profit after taxes 2022: € 13,511 First fiscal year in the series	€ 8,085 Profit after taxes 2023: € 8,085 ▼ 40% vs 2022 (€ 13,511) Unfavourable step	€ 19,591 Profit after taxes 2024: € 19,591 ▲ 142% vs 2023 (€ 8,085) Favourable step	€ 16,135 Profit after taxes 2025: € 16,135 ▼ 18% vs 2024 (€ 19,591) Unfavourable step	▼ 18%
Equity	€ 51,683 Equity 2022: € 51,683 First fiscal year in the series	€ 35,768 Equity 2023: € 35,768 ▼ 31% vs 2022 (€ 51,683) Unfavourable step	€ 44,359 Equity 2024: € 44,359 ▲ 24% vs 2023 (€ 35,768) Favourable step	€ 53,494 Equity 2025: € 53,494 ▲ 21% vs 2024 (€ 44,359) Favourable step	▲ 21%
Total debts	€ 5,497 Total debts 2022: € 5,497 First fiscal year in the series	€ 42,091 Total debts 2023: € 42,091 ▲ € 36,594 vs 2022 (€ 5,497) Unfavourable step	€ 46,257 Total debts 2024: € 46,257 ▲ 10% vs 2023 (€ 42,091) Unfavourable step	€ 37,197 Total debts 2025: € 37,197 ▼ 20% vs 2024 (€ 46,257) Favourable step	▼ 20%
Cash	€ 30,451 Cash 2022: € 30,451 First fiscal year in the series	€ 36,934 Cash 2023: € 36,934 ▲ 21% vs 2022 (€ 30,451) Favourable step	€ 49,863 Cash 2024: € 49,863 ▲ 35% vs 2023 (€ 36,934) Favourable step	€ 55,251 Cash 2025: € 55,251 ▲ 11% vs 2024 (€ 49,863) Favourable step	▲ 11%
Retained profit	€ 48,683 Retained profit 2022: € 48,683 First fiscal year in the series	€ 32,768 Retained profit 2023: € 32,768 ▼ 33% vs 2022 (€ 48,683) Unfavourable step	€ 41,359 Retained profit 2024: € 41,359 ▲ 26% vs 2023 (€ 32,768) Favourable step	€ 50,494 Retained profit 2025: € 50,494 ▲ 22% vs 2024 (€ 41,359) Favourable step	▲ 22%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 24,000 Dividend 2023: € 24,000 Unchanged (€ 0) Unchanged	€ 11,000 Dividend 2024: € 11,000 ▼ 54% vs 2023 (€ 24,000) Unchanged	€ 7,000 Dividend 2025: € 7,000 ▼ 36% vs 2024 (€ 11,000) Unchanged	▼ 36%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 34,767 Bank debt 2023: € 34,767 Unchanged (€ 0) Unfavourable step	€ 30,782 Bank debt 2024: € 30,782 ▼ 11% vs 2023 (€ 34,767) Favourable step	€ 26,558 Bank debt 2025: € 26,558 ▼ 14% vs 2024 (€ 30,782) Favourable step	▼ 14%
Balance sheet total	€ 57,181 Balance sheet total 2022: € 57,181 First fiscal year in the series	€ 77,859 Balance sheet total 2023: € 77,859 ▲ 36% vs 2022 (€ 57,181) Unchanged	€ 90,616 Balance sheet total 2024: € 90,616 ▲ 16% vs 2023 (€ 77,859) Unchanged	€ 90,692 Balance sheet total 2025: € 90,692 Unchanged (€ 90,616) Unchanged

Key figures of Dr. J-P Similon Médecine Générale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. J-P Similon Médecine Générale?

What happened at Dr. J-P Similon Médecine Générale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 16,135 (▼ 18% vs 2024). filed late Source: NBB ↗
Sep 4, 2019 New establishment in Jemeppe-sur-Sambre. KBO
2019 ANNE DEOM became a director. NBB
2019 JEAN-POL SIMILON became a director. NBB
Sep 4, 2019 Start of the company according to the CBE. KBO

In short

From € 13,511 profit in 2022 to € 16,135 profit in 2025.

Paid € 23,410 in corporate taxes since 2022.

Best year ever: 2024, with € 19,591 profit.

Paid out € 42,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

ANNE DEOM JEAN-POL SIMILON

Dr. J-P Similon Médecine Générale

Behind Dr. J-P Similon Médecine Générale are ANNE DEOM and JEAN-POL SIMILON.

Directors

According to the 2025 annual accounts

ANNE DEOM

Director

since 2019

JEAN-POL SIMILON

Administrator-manager

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Station,Moustier 189

5190 Jemeppe-sur-Sambre

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0733.707.901
VAT number: BE 0733.707.901
Registered office: Rue de la Station,Moustier 189, 5190 Jemeppe-sur-Sambre
Names & denominations: Dr. J-P Similon Médecine Générale
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 September 2019
Peppol: Not registered
Contact: [email protected] +3271780296

View on CBE Public ↗ Annual accounts (NBB) ↗